Search Within

Andrei Vladimirovich Krivtsov

Formats
  1. Journal Article (21)
  2. Meeting Abstract (15)
  3. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (23)
  2. GSK Faculty (20)
  3. Adult Leukemia (17)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (17)
  5. Department of Medicine (17)
  6. Hematologic Malignancies, Division of (17)

More Groups

People
  1. Scott Armstrong (33)
  2. Richard Koche (17)
  3. Ross Levine (13)
  4. Martin Tallman (8)
  5. Alan Chramiec (6)
  6. Elisa De Stanchina (6)

More People

Years
  1. 2018 (4)
  2. 2017 (6)
  3. 2016 (8)
  4. 2015 (10)
  5. 2014 (4)
  6. 2013 (4)

More Years

Publications
  1. Blood (16)
  2. Nature Medicine (4)
  3. Leukemia (3)
  4. Clinical Cancer Research (2)
  5. Nature Genetics (2)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. Nature Publishing Group (11)
  3. American Association for Cancer Research (3)
  4. Cell Press (2)
  5. Academic Press, Elsevier Inc (1)
  6. American Association for the Advancement of Science (1)

More Publishers

Results (37)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RNA binding protein SYNCRIP regulates the leukemia stem cell program
    Meeting Abstract

    Vu, L. P.; Prieto, C.; Amin, E.; Minuesa, G.; Chhangawala, S.; Vidal, M. J.; Krivtsov, A. V.; Chou, T.; Barlowe, T.; Taggart, J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • An epigenetic regulator screen identifies novel targets that sensitize MLL-rearranged leukemia to DOT1L inhibition
    Meeting Abstract

    Chen, C. W. D.; Delaney, C.; Xu, H.; Koche, R.; Goizueta, A. L.; Hoshii, T.; Cusan, M.; Chabon, J.; Valerio, D. G.; Kuehn, M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Aberrant phosphorylation of MEF2C is dispensable for hematopoiesis, and induces chemotherapy resistance and susceptibility to MARK kinase inhibition therapy in acute myeloid leukemia
    Meeting Abstract

    Brown, F. C.; Still, E.; Cifani, P.; Reed, C.; Ficarro, S.; He, J.; Koche, R.; Bhola, P.; Romanienko, P.; Mark, W.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Final report of phase 1 study of the DOT1L inhibitor, pinometostat (EPZ-5676), in children with relapsed or refractory MLL-r acute leukemia
    Meeting Abstract

    Shukla, N.; Wetmore, C.; O'Brien, M. M.; Silverman, L. B.; Brown, P.; Cooper, T. M.; Thomson, B.; Blakemore, S. J.; Daigle, S.; Ben, Suttle; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Peptidomimetic blockade of MYB in acute myeloid leukemia
    Meeting Abstract

    Ramaswamy, K.; Forbes, L.; Brown, F. C.; Koche, R.; Gindin, T.; Minuesa, G.; Kharas, M. G.; Krivtsov, A.; Armstrong, S. A.; Still, E.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling
    Journal Article

    Guryanova, O. A.; Shank, K.; Spitzer, B.; Luciani, L.; Koche, R. P.; Garrett-Bakelman, F. E.; Ganzel, C.; Durham, B. H.; Mohanty, A.; Hoermann, G.; more...
    Nature Medicine (2016)

    Fulltext@MSK | Save
  • Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status"
    Journal Article

    LaFave, L. M.; Béguelin, W.; Koche, R.; Teater, M.; Spitzer, B.; Chramiec, A.; Papalexi, E.; Keller, M. D.; Hricik, T.; Konstantinoff, K.; more...
    Nature Medicine (2016)

    Fulltext@MSK | Save
  • Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins
    Journal Article

    Lee, S. C. W.; Dvinge, H.; Kim, E.; Cho, H.; Micol, J. B.; Chung, Y. R.; Durham, B. H.; Yoshimi, A.; Kim, Y. J.; Thomas, M.; more...
    Nature Medicine (2016)

    Fulltext@MSK | Save
  • A phase 1 study of the DOT1L inhibitor, pinometostat (EPZ-5676), in adults with relapsed or refractory leukemia: Safety, clinical activity, exposure and target inhibition
    Meeting Abstract

    Stein, E. M.; Garcia-Manero, G.; Rizzieri, D. A.; Tibes, R.; Berdeja, J. G.; Jongen-Lavrencic, M.; Altman, J. K.; Dohner, H.; Thomson, B.; Blakemore, S. J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Preliminary report of the phase 1 study of the DOT1L inhibitor, pinometostat, EPZ-5676, in children with relapsed or refractory MLL-r acute leukemia: Safety, exposure and target inhibition
    Meeting Abstract

    Shukla, N.; O'Brien, M. M.; Silverman, L. B.; Pauly, M.; Wetmore, C.; Loh, M. L.; Whitlock, J. A.; Brown, P.; Thomson, B.; Blakemore, S. J.; more...
    Blood (2015)

    Fulltext@MSK | Save